Inventor

SU TSANN-LONG

US14 patents

⚠️ This page may combine multiple inventors who share the name “SU TSANN-LONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ACADEMIA SINICA

4 patents

US9662324B2May 30, 2017

Methods and compositions for treating β-thalassemia and sickle cell disease

ACADEMIA SINICA3 citations69

US6821983B2Nov 23, 2004

5-(9-acridinylamino)-toluidine compounds

ACADEMIA SINICA1 citations51

US11066412B2Jul 20, 2021

Substituted pyrrolo[2,1-a]phthalazines and benzo[g]pyrrolo[2,1-a]phthalazines for the treatment of cancer

ACADEMIA SINICA0 citations46

US10548861B2Feb 4, 2020

Use of ureidomustine (BO-1055) in cancer treatment

ACADEMIA SINICA0 citations43

SLOAN KETTERING INST CANCER

4 patents

US5354864AOct 11, 1994

SU TSANN-LONG

4 patents

US8222297B2Jul 17, 2012

Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents

SU TSANN-LONG4 citations60

US8703951B2Apr 22, 2014

Synthesis of 4H-benzo[D]pyrrolo[1,2-A]thiazoles and indolizino[6,7-b]indole derivatives and their use as antitumor therapeutic agents

SU TSANN-LONG0 citations46

US9193687B2Nov 24, 2015

Phenyl N-mustard linked to DNA-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents

SU TSANN-LONG0 citations43

US8410130B2Apr 2, 2013

Synthesis of 8H-3A-aza-cyclopenta [A ]indenes and 5,10-dihydropyrrolo[1,2-B]isoquinolines derivatives and their use as antitumor therapeutic agents

SU TSANN-LONG0 citations39

NAT HEALTH RESEARCH INST

1 patent

US5939428AAug 17, 1999

Alkyl N- 3-(acridin-9-yl)amino-5-hydroxymethyl! phenylcarbamates

NAT HEALTH RESEARCH INST6 citations53

LEE TE-CHANG

1 patent

US8772284B2Jul 8, 2014

Method of treating cancer using combination of a bifunctional alkylating agent and DNA repair inhibitors

LEE TE-CHANG0 citations42

SU TSANN-LONG

ACADEMIA SINICA

Methods and compositions for treating β-thalassemia and sickle cell disease

5-(9-acridinylamino)-toluidine compounds

Substituted pyrrolo[2,1-a]phthalazines and benzo[g]pyrrolo[2,1-a]phthalazines for the treatment of cancer

Use of ureidomustine (BO-1055) in cancer treatment

SLOAN KETTERING INST CANCER

3-(9-acridinylamino)-5-hydroxymethylaniline derivatives as anticancer agents

Antitumor cyclopentnaphthoquinone and cyclopentanthraquinone derivatives

Substituted 1-phenylnaphthalenes

Multisubstituted 1-hydroxy-9-acridones with anticancer activity

SU TSANN-LONG

Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents

Synthesis of 4H-benzo[D]pyrrolo[1,2-A]thiazoles and indolizino[6,7-b]indole derivatives and their use as antitumor therapeutic agents

Phenyl N-mustard linked to DNA-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents

Synthesis of 8H-3A-aza-cyclopenta [A ]indenes and 5,10-dihydropyrrolo[1,2-B]isoquinolines derivatives and their use as antitumor therapeutic agents

NAT HEALTH RESEARCH INST

Alkyl N- 3-(acridin-9-yl)amino-5-hydroxymethyl! phenylcarbamates

LEE TE-CHANG

Method of treating cancer using combination of a bifunctional alkylating agent and DNA repair inhibitors